Item 5.07. Submission of Matters to a Vote of Security Holders.

Akero Therapeutics, Inc. (the "Company") held its Annual Meeting of Stockholders (the "Annual Meeting") on June 1, 2021. As of April 5, 2021, the record date for the Annual Meeting, there were 34,820,319 outstanding shares of the Company's common stock. The Company's stockholders voted on the following matters, which are described in detail in the Company's Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission ("SEC") on April 27, 2021: (i) to elect three directors, Seth L. Harrison, M.D., Graham Walmsley, M.D., Ph.D., and Yuan Xu, Ph.D., as Class II directors of the Company to each serve for a three-year term expiring at the Company's annual meeting of stockholders in 2024 and until their successors have been duly elected and qualified, subject to their earlier death, resignation or removal ("Proposal 1") and (ii) to ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021 ("Proposal 2").

The Company's stockholders approved the Class II director nominees recommended for election in Proposal 1 at the Annual Meeting. The Company's stockholders voted for Class II directors as follows:





    Class II Director Nominee          For           Withheld        Broker Non-Votes
    Seth L. Harrison, M.D.           21,800,912       4,780,457           5,298,544
    Graham Walmsley, M.D., Ph.D.     21,775,483       4,805,886           5,298,544
    Yuan Xu, Ph.D.                   26,548,435        32,934             5,298,544

The Company's stockholders approved to ratify the appointment of Deloitte & Touche LLP in Proposal 2. The votes cast at the Annual Meeting were as follows:





                             For          Against      Abstain
                           31,788,019       12,437       79,457

No other matters were submitted to or voted on by the Company's stockholders at the Annual Meeting.





                                  *    *     *

© Edgar Online, source Glimpses